Clinical Trial Update: Long Term Open Label Continuation Study [Phase 3]

View source ↗

Summary

This update notes the completion of a long-term open-label extension study in Phase 3 for rheumatoid arthritis conducted by Abbott, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-07-31